Track Conformis's total revenue ($57M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2023
Trailing 12 months ending Jun 2023
As of the most recent data (June 2023), CFMS shows a total revenue of $57M. That compares with $61M in the prior-year period — down 5.7% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CFMS's total revenue is now $57M (was $61M) — a 5.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Conformis is outperforming or lagging.
The Healthcare sector average total revenue is about $110B. Conformis is at $57M, which is lower that average. That is roughly 99.9% below the sector mean. Use the comparison chart on this page to see how CFMS stacks up against individual peers as well.
Tracking CFMS's total revenue over time shows whether Conformis is scaling, shrinking, or reshaping that part of the business. The current reading is $57M That compares with $61M in the prior-year period — down 5.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has Conformis's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $57M) with ownership activity and broader fundamentals.